MURLI KRISHNA PHARMA PVT LTD

Overview

MURLI KRISHNA PHARMA PVT LTD is an active pharmaceutical ingredient (API) supplier with 9 active FDA Type II Drug Master Files, covering CLARITHROMYCIN PELLETS 42.0 % W/W; DULOXETINE EC PELLETS 17.0% W/W; ESOMEPRAZOLE PELLETS 22.5% W/W; ITRACONAZOLE PELLETS 22.0 % W/W; LANSOPRAZOLE PELLETS 8.5 % W/W; OMEPRAZOLE PELLETS 8.5 % W/W.

API / Drug Master Files

MURLI KRISHNA PHARMA PVT LTD holds 9 active (9 total) FDA Type II Drug Master Files — identifying it as an active-substance / API supplier. Type II DMFs are filed with the FDA to support the use of an active pharmaceutical ingredient in drug applications.

• DULOXETINE EC PELLETS 17.0% W/WActive2024-05-31
• ESOMEPRAZOLE PELLETS 22.5% W/WActive2024-03-19
• ORLISTAT PELLETS 50.0% W/WActive2016-08-01
• ORLISTAT PELLETS 50.0% W/WActive2013-09-23
• TACROLIMUS PELLETS 5.0% W/WActive2013-09-23
• ITRACONAZOLE PELLETS 22.0 % W/WActive2013-08-01
• OMEPRAZOLE PELLETS 8.5 % W/WActive2013-08-01
• LANSOPRAZOLE PELLETS 8.5 % W/WActive2013-08-01
• CLARITHROMYCIN PELLETS 42.0 % W/WActive2013-08-01

FDA compliance signals

No FDA recalls, Warning Letters, or Form 483 observations are linked to MURLI KRISHNA PHARMA PVT LTD in our records. PharmaTek screens the full directory against live FDA enforcement data.